Related Experiment Video
Updated: Feb 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Thomas H Marwick1, Rebecca Ritchie1, Jonathan E Shaw1
1Baker Heart and Diabetes Institute, Melbourne, Australia.
Insights
Diabetes and obesity increase heart failure risk, often with preserved ejection fraction. This review explores the complex links, focusing on molecular mechanisms and potential therapies for diabetic cardiomyopathy.
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Heart failure incidence and prevalence rise with diabetes mellitus, pre-diabetes, and obesity.
- Heart failure in these conditions often presents as heart failure with preserved ejection fraction, even without significant coronary artery disease.
- The direct link to a primary diabetic cardiomyopathy is obscured by confounding factors like hypertension and autonomic neuropathy.
Purpose of the Study:
- To review recent advances in understanding the molecular mechanisms of myocardial dysfunction in diabetes.
- To discuss limitations in current knowledge and clinical screening for diabetic heart conditions.
- To explore potential therapeutic strategies for heart failure associated with diabetes and metabolic disorders.
Main Methods:
- Literature review of epidemiological, mechanistic, and clinical studies.
- Analysis of systemic, cardiac, and cellular/molecular associations with heart dysfunction.
- Synthesis of information on screening methods and therapeutic targets.
Main Results:
- Epidemiological data strongly link diabetes to increased heart failure risk and poorer outcomes.
- Mechanistic insights reveal impaired cardiac relaxation, compliance, and contractility due to diabetes.
- Confounding factors complicate the definitive identification of a unique diabetic cardiomyopathy.
Conclusions:
- Despite confounding factors, compelling evidence supports distinct myocardial changes in diabetes.
- Further research into molecular pathways is crucial for developing targeted therapies.
- Integrating molecular understanding with clinical practice is key to managing heart failure in diabetic populations.
Abstract:
Heart failure is a complex clinical syndrome, the incidence and prevalence of which is increased in diabetes mellitus, pre-diabetes, and obesity. Although this may arise from underlying coronary artery disease, it often occurs in the absence of significant major epicardial coronary disease, and most commonly manifests as heart failure with preserved ejection fraction. Despite epidemiological evidence linking diabetes to heart failure incidence and outcome, the presence of a distinct primary "diabetic" cardiomyopathy has been difficult to prove, because the link between diabetes and heart failure is confounded by hypertension, microvascular dysfunction, and autonomic neuropathy. Nonetheless, several mechanistic associations at systemic, cardiac, and cellular/molecular levels explain different aspects of myocardial dysfunction, including impaired cardiac relaxation, compliance, and contractility. This review seeks to describe recent advances and limitations pertinent to integrating molecular mechanisms, clinical screening, and potential therapeutic avenues for this condition.
More Related Videos
Related Concept Videos
Cardiomyopathy VI: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

